MR-Based Radiomics Signature As Surrogate of Hepatic Venous Pressure Gradient for Clinically Significant Portal Hypertension in Advanced Chronic Liver Disease: A Prospective Multicenter Study
文献类型:期刊论文
作者 | Liu, Chuan1; Luo, Jiaxiu2; An, Weimin3; Huang, Yifei1; Wang, Guangchuan4; Zou, Jialiang1; Liu, Zhao1; Zhou, Zhibo1; Ning, Zhenyuan2; Wang, Sining4 |
刊名 | HEPATOLOGY
![]() |
出版日期 | 2018-10-01 |
卷号 | 68页码:472A-473A |
ISSN号 | 0270-9139 |
WOS研究方向 | Gastroenterology & Hepatology |
语种 | 英语 |
WOS记录号 | WOS:000446020501009 |
出版者 | WILEY |
源URL | [http://ir.ia.ac.cn/handle/173211/23061] ![]() |
专题 | 自动化研究所_中国科学院分子影像重点实验室 |
作者单位 | 1.Southern Med Univ, Nanfang Hosp, Inst Hepatol, Hepat Hemodynam Lab, Guangzhou, Guangdong, Peoples R China 2.Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China 3.302 Hosp PLA, Dept Radiol, Beijing, Peoples R China 4.Shandong Univ, Shandong Prov Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China 5.Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing, Peoples R China 6.PLA Army Gen Hosp, Inst Hepatol, Beijing, Peoples R China 7.Nanfang Hosp, Guangzhou, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Liu, Chuan,Luo, Jiaxiu,An, Weimin,et al. MR-Based Radiomics Signature As Surrogate of Hepatic Venous Pressure Gradient for Clinically Significant Portal Hypertension in Advanced Chronic Liver Disease: A Prospective Multicenter Study[J]. HEPATOLOGY,2018,68:472A-473A. |
APA | Liu, Chuan.,Luo, Jiaxiu.,An, Weimin.,Huang, Yifei.,Wang, Guangchuan.,...&Qi, Xiaolong.(2018).MR-Based Radiomics Signature As Surrogate of Hepatic Venous Pressure Gradient for Clinically Significant Portal Hypertension in Advanced Chronic Liver Disease: A Prospective Multicenter Study.HEPATOLOGY,68,472A-473A. |
MLA | Liu, Chuan,et al."MR-Based Radiomics Signature As Surrogate of Hepatic Venous Pressure Gradient for Clinically Significant Portal Hypertension in Advanced Chronic Liver Disease: A Prospective Multicenter Study".HEPATOLOGY 68(2018):472A-473A. |
入库方式: OAI收割
来源:自动化研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。